Drug delivery systems provider Aptar Pharma has released PureHale, a new portable and ready-to-use drug delivery product designed for upper respiratory care.
PureHale is designed to be a revolutionary and intuitive device which, when used in combination with saline or other natural ingredient formulations, helps relieve the symptoms of upper respiratory system conditions. The PureHale technology platform benefits include:
• Use of non-electronic technology eliminates need to plug in or charge
• Quieter and lighter than traditional nebulizers
• Complete portability and always ready to use
• Includes mask and mouthpiece options, offering adaptable treatment and suitable for family use
• Continuous cooling mist with fine particles (20-30μm) optimized for targeted deposition to the upper airways
With the ongoing rise in pollution, the need for upper respiratory relief is more prominent than ever. PureHale’s technology distributes a continuous fine mist that gently cleanses, moisturizes and soothes the upper respiratory tract, in turn helping to reduce irritations caused by coughs, colds, allergies, respiratory problems and dry nose/throat issues.
PureHale’s portability allows consumers to relieve their symptoms wherever and whenever needed. Developed after researching and analyzing the benefits and challenges of traditional nebulizer technology, this new user-friendly system was engineered for on-the-go consumers. Unlike traditional nebulizers, the PureHale system does not require batteries or the prefilling of a reservoir.
Aptar Pharma recognized the need for a device of this kind, noting that traditional nebulizers come with a set of challenges including complexities in setup, manual dexterity requirements and overall usage time. Meanwhile, challenges during medication administration include poor inhalation technique, duration of nebulization and understanding how to achieve optimal efficacy.
Aptar Pharma has long been committed to breaking ground in healthcare technologies and working with partners to open up new markets with innovative delivery routes. Utilizing Aptar Pharma’s well-established Bag-on-Valve technology, the PureHale system preserves the integrity of the treatment solution while utilizing compressed air/nitrogen between the bag and can to create a continuous mist when actuated. This solution is valuable to pharmaceutical partners seeking a system that can carry a range of formulations, comes in various container sizes, while also offering differentiating and branding advantages.
PureHale aims to enable pharmaceutical partners the ability to expand their audience reach for their brand formulations, providing portable, symptomatic relief for upper respiratory system conditions, providing brand differentiation via a range of personalization options.
With minimal parameter changes, existing filling processes can be easily adapted to fill PureHale.